VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹31 Cr | ₹30 Cr | ₹40 Cr | ₹11 Cr | ₹0.16 Cr |
What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹0.16 Cr |
How is Contingent Liabilities of VENUS REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 0.51 | |
| Mar2024 | ₹30 Cr | -23.13 | |
| Mar2023 | ₹40 Cr | 272.42 | |
| Mar2022 | ₹11 Cr | 6,423.93 | |
| Mar2021 | ₹0.16 Cr | - | |
Compare Contingent Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,395.0 Cr | -5.4% | 1.6% | 262.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -5.4% |
1.6% |
262.2% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses